A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid Arthritis
Status:
Active, not recruiting
Trial end date:
2021-12-13
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the efficacy, safety, and pharmacokinetics (PK) of
VIB4920 (formerly MEDI4920) in adult participants with Rheumatoid Arthritis (RA).